Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment Henríquez-Hernández, Luis Alberto Valenciano, Almudena Foro-Arnalot, Palmira Álvarez Cubero, María Jesús Cózar Olmo, José Manuel Suárez-Novo, José Francisco Castells-Esteve, Manel Fernández-Gonzalo, Pablo De-Paula-Carranza, Belén Ferrer, Montse Guedea, Ferrán Sancho-Pardo, Gemma Craven-Bartle, Jordi Ortiz-Gordillo, María José Cabrera-Roldán, Patricia Herrera-Ramos, Estefanía Rodríguez-Gallego, Carlos Lara, Pedro C. 5-alpha-reductase polymorphism 5-alpha-reductase inhibitors OpenArray Prostate cancer Pharmacoethnicity We designed a study aimed to evaluate the genotypic distribution of 22 SNPs in SRD5A1 and SRD5A2 in a set of Spanish prostate cancer patients, to determine the homogeneity of the population and to disclose potential bias associated with the failure of 5α-RI when prescribed. 2015-09-03T10:54:30Z 2015-09-03T10:54:30Z 2015 info:eu-repo/semantics/article Henríquez-Hernández, L.A.; et al. Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment. Journal of Genetics, 94(2): 335-341 (2015). [http://hdl.handle.net/10481/37238] 0022-1333 http://hdl.handle.net/10481/37238 eng info:eu-repo/semantics/openAccess Indian Academy of Sciences